2022-11-015 + 2018-04-015 + 2017-03-017 - ISCHEMBURG - 3 - Minimally-invasive microsensors for ischemia detection

ISCHEMSURG IS A DISPOSABLE MEDICAL DEVICE THAT CONTAINS A MINITURIZED ELECTRONIC SENSORS (SIZE LESSTHAN 1mm) FOR A MINIMALLY INVASIVE MONITORING OF TISSUE ISCHEMIA

Contacts

ES

Eduardo SalasHead. Technology Transfer and Business Development Office
Institut de Bioenginyeria de Catalunya (IBEC)

Acronim & Gínjol codes

ACRONYM

ISCHEMBURG - 3

2022-11-015 + 2018-04-015 + 2017-03-017

Main technology offer

A disposable and miniaturized array of electrochemical sensors for the minimally invasive monitoring of tissue ischemia. This wireless sensor permits the continuous control of deep tissues, whose blood perfusion may be compromised

Public Partners

Centres CERCA List

Readiness Level

1-2 Research / 3-4 Experimental PoC / 5 Prototype / 6-7 MVP / 8 Industrialization / 9 Commercialization

MIN

1

2

3

4

5

6

7

8

9

10

MAX

1-First Canvas / 2-Market Analysis / 3-First Validation / 4-MVP / 5-Market Fit / 6-Validate Sales / 7-Final MPV / 8-Validate Business Model / 9-Key Metrics

MIN

1

2

3

4

5

6

7

8

9

10

MAX

1-Market hypothesis / 2-Basic Market / 3-PoC / 4-Target Customer / 5- Customer Validation / 6-Launchable MVP / 7-Customer feedback / 8-Scale product-service / 9-Sustainable business

MIN

1

2

3

4

5

6

7

8

9

10

MAX

Impact: ESG & SDG Goals

Sustainable Development Goals

Market Data

Free flaps (autologus tissues for surgery reconstruction) are used on all kind of reparative surgeries. The main risk of failure are post-surgical microvascular compications on the anastomotic sites, which causes ischemia and tissue necrosis. Similarly, trauma units struggle to correctly diagnose compatimental syndrome, which requires extremely invasive surgical operation to avoid severe morbility consequences due to ischemia. In both cases the control of tissue ischemia is critical. However, nowadays the diagnosis os isehcmia is based on the clincial observation of subjetive symptoms. Therefore, microcirculatory complications are normally detected too late. Thus, early detection of tissue ischemia is a primary aim on microsurgical and trauma units.

948500000

253330000

143000

The business model is a clasical B2B with two branches. The first one is selling the sensor, transmiter and reader to hospitals (surgery and traumatology departments) and the second one is selling the sensors that will be inserted to the patients.

Early detection of tissue ischemia is a primary aim on microsurgical and trauma units.

1) Reader and transmiter. There are approximately 165.000 hospitals in the word. 2) Sensors.Globally there are 40 millon new tibia fractures and compartimental syndrom is a complication in 40% 3) As average in US and Europe there are 200.000 flap surgery 4) Critical limb ischemia: The global annual incidence is estimated at 22 per 100.000 habitants. In the population older than 65, the incidence is 113-200 per 100.000 habitants

DeepTech Area

Funding

A technological center willing to peform the scale up of the manufacture, and to obtain the CE mark for in vitro diagnostic in accordance to IVDR 2017/746.

0.- Finding a technological center / company interested 1.- Scaling and performing the necessary studies as to obtain CE mark for IVD 2.- Commercialization

Technology Status

Initiated national phases in EP, US, CA, CN, and JP

Additional information

Patents: EP20382702.7

Can be carried out by both physicians and caregiver professionals. Small dimensions of the sensor and the probe design, it permits to be easily removed from the site of insertion with minimal pain and risk. In case of ischemia complications, it will permit an immediate surgical response before irreversible tissue damage occurs.